Meeting Banner
Abstract #4557

Evaluation of cardiotoxicity in chest tumor patients receiving immune checkpoint inhibitors by cardiovascular magnetic resonance

Jia Liu1, Yukun Cao1, Kuikui Zhu1, Sheng Yao2, Mei Yuan1, Xiangchuang Kong1, Xiaoming Liu1, Yumin Li1, Yue Cui1, Xiaoyu Han1, Xiaoyue Zhou3, Rui Meng1, and Heshui Shi1
1wuhan union hospital, wuhan, China, 2wuhan tongji hospital, wuhan, China, 3Siemens Healthcare, shanghai, China

Synopsis

In our study, we conducted a prospective study to investigate the subclinical cardiotoxicity by serial cardiovascular magnetic resonance (CMR) in patients receiving immune checkpoint inhibitor (ICI). Some functional parameters and global strains of bi-ventricles revealed significant decrease at the early stage on ICI therapy, and ejection fraction as well as global strain values of both ventricles all showed a decline trend. Tissue characterization is an extra advantage of CMR technique. While in our study, parameters (T1 mapping, T2 mapping and late gadolinium enhancement) regarding tissue characterization of global myocardium showed no significant differences, compared with baseline data.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords